Skip to content
Search

Latest Stories

Trump says trade deal with India ‘very close’

"We're very close to India, and ... we could possibly make a deal with (the) EU," Trump said when asked about upcoming trade agreements.

Trump

Trump’s administration has been working on trade deals ahead of an August 1 deadline, when duties on most US imports are scheduled to rise again. (Photo: Getty Images)

Getty Images

THE US is very close to finalising a trade agreement with India, while a deal with the European Union is also possible, president Donald Trump said in an interview aired on Real America's Voice on Wednesday. However, he said it was too soon to tell if an agreement could be reached with Canada.

Trump’s administration has been working on trade deals ahead of an August 1 deadline, when duties on most US imports are scheduled to rise again. The push is part of efforts to secure what Trump considers better trade terms and reduce the large US trade deficit.


"We're very close to India, and ... we could possibly make a deal with (the) EU," Trump said when asked about upcoming trade agreements.

Trump’s comments came as EU trade chief Maros Sefcovic travelled to Washington on Wednesday for discussions on tariffs. An Indian trade delegation also arrived in Washington on Monday for fresh negotiations.

"(The) European Union has been brutal, and now they're being very nice. They want to make a deal, and it'll be a lot different than the deal that we've had for years," Trump said.

On Canada, which has said it is preparing countermeasures if talks do not lead to an agreement, Trump said: "Too soon to say."

His remarks echoed the view of Canadian prime minister Mark Carney, who said earlier on Wednesday that a deal that works for Canadian workers was not yet on the table.

Trump also said he would probably impose a blanket 10 per cent or 15 per cent tariff on smaller countries.

(With inputs from agencies)

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less